The NOAH-AFNET 6 trial shows that giving a direct oral anticoagulant to patients with these device-detected arrhythmias has no benefits and increases risks.
Birmingham researchers will target Galectin-9, a protein involved in thrombo-inflammation processes.
The antibody targets a section of signalling proteins that play a central role in sustaining inflammation during onset and progression of autoimmune diseases
Researchers from the University of Birmingham will work with Roche to identify new avenues for treatment for Inflammatory Bowel Disease.
A new national strategy document, released today, should help aid progress in congenital heart disease research through greater collaboration between centres.
First study to show ageing is factor in sex differences between immune cell movement around the body
Hypertension patients could receive a personalised medication profile thanks to a new, artificial intelligence-supported research project.
In the only randomised controlled trial of its kind, BASIL-2 enrolled 345 patients in 41 vascular surgery centres in UK, Sweden and Denmark
Blood clot researchers could benefit from a new device that mimics a human vein, replacing the need for animals for some studies.
Dr Pavlovic has been elected to join a group of 12 distinguished European cardiovascular researchers from the International Society for Heart Research (ISHR).